376 related articles for article (PubMed ID: 14691455)
21. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
[TBL] [Abstract][Full Text] [Related]
22. Opposite long-term regulation of c-Myc and p27Kip1 through overactivation of Raf-1 and the MEK/ERK module in proliferating human choroidal melanoma cells.
Lefevre G; Calipel A; Mouriaux F; Hecquet C; Malecaze F; Mascarelli F
Oncogene; 2003 Dec; 22(55):8813-22. PubMed ID: 14654778
[TBL] [Abstract][Full Text] [Related]
23. Mixed-lineage kinase inhibitors require the activation of Trk receptors to maintain long-term neuronal trophism and survival.
Wang LH; Paden AJ; Johnson EM
J Pharmacol Exp Ther; 2005 Mar; 312(3):1007-19. PubMed ID: 15525794
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
[TBL] [Abstract][Full Text] [Related]
25. c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade.
Desbiens KM; Deschesnes RG; Labrie MM; Desfossés Y; Lambert H; Landry J; Bellmann K
Biochem J; 2003 Jun; 372(Pt 2):631-41. PubMed ID: 12646044
[TBL] [Abstract][Full Text] [Related]
26. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.
Sugimoto T; Kuroda H; Horii Y; Moritake H; Tanaka T; Hattori S
Jpn J Cancer Res; 2001 Feb; 92(2):152-60. PubMed ID: 11223544
[TBL] [Abstract][Full Text] [Related]
27. Constitutive N-myc gene expression inhibits trkA mediated neuronal differentiation.
Bogenmann E; Torres M; Matsushima H
Oncogene; 1995 May; 10(10):1915-25. PubMed ID: 7761093
[TBL] [Abstract][Full Text] [Related]
28. Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling.
Plo I; Bono F; Bezombes C; Alam A; Bruno A; Laurent G
J Neurosci Res; 2004 Aug; 77(4):465-74. PubMed ID: 15264216
[TBL] [Abstract][Full Text] [Related]
29. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
30. MKK7γ1 reverses nerve growth factor signals: proliferation and cell death instead of neuritogenesis and protection.
Haeusgen W; Herdegen T; Waetzig V
Cell Signal; 2011 Aug; 23(8):1281-90. PubMed ID: 21406225
[TBL] [Abstract][Full Text] [Related]
31. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
[TBL] [Abstract][Full Text] [Related]
32. Novel functional interactions between Trk kinase and p75 neurotrophin receptor in neuroblastoma cells.
Lachyankar MB; Condon PJ; Daou MC; De AK; Levine JB; Obermeier A; Ross AH
J Neurosci Res; 2003 Jan; 71(2):157-72. PubMed ID: 12503079
[TBL] [Abstract][Full Text] [Related]
33. Effects of thimerosal on NGF signal transduction and cell death in neuroblastoma cells.
Parran DK; Barker A; Ehrich M
Toxicol Sci; 2005 Jul; 86(1):132-40. PubMed ID: 15843506
[TBL] [Abstract][Full Text] [Related]
34. Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKA.
Rende M; Brizi E; Conner J; Treves S; Censier K; Provenzano C; Taglialatela G; Sanna PP; Donato R
Int J Dev Neurosci; 2000 Dec; 18(8):869-85. PubMed ID: 11154856
[TBL] [Abstract][Full Text] [Related]
35. Heparanase enhances nerve-growth-factor-induced PC12 cell neuritogenesis via the p38 MAPK pathway.
Cui H; Shao C; Liu Q; Yu W; Fang J; Yu W; Ali A; Ding K
Biochem J; 2011 Dec; 440(2):273-82. PubMed ID: 21831044
[TBL] [Abstract][Full Text] [Related]
36. Specific TrkA survival signals interfere with different apoptotic pathways.
Ulrich E; Duwel A; Kauffmann-Zeh A; Gilbert C; Lyon D; Rudkin B; Evan G; Martin-Zanca D
Oncogene; 1998 Feb; 16(7):825-32. PubMed ID: 9484773
[TBL] [Abstract][Full Text] [Related]
37. NGF is involved in oral ovalbumin-induced altered colonic contractility in rats: evidence from the blockade of TrkA receptors with K252a.
Jardí F; Martínez V; Vergara P
Neurogastroenterol Motil; 2012 Dec; 24(12):e580-90. PubMed ID: 23072452
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of TrkA in cumulus oocyte complexes (COCs) inhibits EGF-induced cumulus expansion by down-regulation of IL-6.
Wang Y; Liang N; Yao G; Tian H; Zhai Y; Yin Y; Sun F
Mol Cell Endocrinol; 2014 Feb; 382(2):804-13. PubMed ID: 24215827
[TBL] [Abstract][Full Text] [Related]
39. A novel cyclophane compound, CPPy, facilitates NGF-induced TrkA signal transduction and induces cell differentiation in neuroblastoma.
Yamaguchi Y; Tabata K; Asami S; Miyake M; Suzuki T
Biol Pharm Bull; 2007 Apr; 30(4):638-43. PubMed ID: 17409494
[TBL] [Abstract][Full Text] [Related]
40. Acidic substitution of the activation loop tyrosines in TrkA supports nerve growth factor-dependent, but not nerve growth factor-independent, differentiation and cell cycle arrest in the human neuroblastoma cell line, SY5Y.
Gryz EA; Meakin SO
Oncogene; 2003 Nov; 22(54):8774-85. PubMed ID: 14647472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
